Latest Stories
Ladder Capital (LADR): Buy, Sell, or Hold Post Q3 Earnings?
Since July 2025, Ladder Capital has been in a holding pattern, posting a small return of 1.2% while floating around $10.99. The stock also fell short of the S&P 500’s 11.2% gain during that period.
2 Reasons to Avoid WK and 1 Stock to Buy Instead
Over the past six months, Workiva has been a great trade, beating the S&P 500 by 15.1%. Its stock price has climbed to $86.29, representing a healthy 26.4% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Sell CDW and 1 Stock to Buy Instead
CDW’s stock price has taken a beating over the past six months, shedding 24.8% of its value and falling to $136.22 per share. This may have investors wondering how to approach the situation.
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how to approach the situation.
2 Reasons PGNY is Risky and 1 Stock to Buy Instead
Over the past six months, Progyny has been a great trade, beating the S&P 500 by 5.2%. Its stock price has climbed to $25.68, representing a healthy 16.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons ADSK is Risky and 1 Stock to Buy Instead
Autodesk currently trades at $297.44 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 11.2% gain during that period.
3 Reasons POWL Has Explosive Upside Potential
What a time it’s been for Powell. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $318.00 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons APPN is Risky and 1 Stock to Buy Instead
Appian’s 16.3% return over the past six months has outpaced the S&P 500 by 5%, and its stock price has climbed to $35.42 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid CADE and 1 Stock to Buy Instead
Over the past six months, Cadence Bank has been a great trade, beating the S&P 500 by 16.8%. Its stock price has climbed to $42.80, representing a healthy 28% increase. This run-up might have investors contemplating their next move.
Renasant (RNST): Buy, Sell, or Hold Post Q3 Earnings?
Over the last six months, Renasant’s shares have sunk to $35.22, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 11.2% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.